Treatment decision‐making among Canadian youth with severe haemophilia: a qualitative approach-Reference-Cited by-同舟云学术

Treatment decision‐making among Canadian youth with severe haemophilia: a qualitative approach

Published:2014-10-09 Issue:2 Volume:21 Page:180-189
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Lane S. J.¹,Walker I.¹,Chan A. K.²,Heddle N. M.¹³,Poon M.‐C.⁴,Minuk L.⁵,Jardine L.⁶,Arnold E.⁷,Sholapur N.¹,Webert K. E.¹⁸⁹

Affiliation:

1. Department of Medicine McMaster UniversityHamilton ON Canada

2. Department of Pediatrics McMaster UniversityHamilton ON Canada

3. Canadian Blood Services, Research and Development Hamilton ONCanada

4. Departments of Medicine, Pediatrics and Oncology University of Calgary Calgary AB Canada

5. Division of Hematology Department of Medicine University of Western Ontario London ON Canada

6. Section of Pediatric Hematology Oncology Department of Pediatrics Schulich School of Medicine and Dentistry University of Western Ontario London ON Canada

7. Department of Social Sciences McMaster University Hamilton ON Canada

8. Canadian Blood Services Medical Office Hamilton ON Canada

9. Department of Pathology and Molecular Medicine McMaster University Hamilton ON Canada

Funder

Canadian Hemophilia Society

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12543

Reference22 articles.

1. Modern treatment of haemophilia;Berntorp E;Bull World Health Organ,1995

2. Prophylactic treatment of severe hemophilia A and B can prevent joint disability;Nilsson IM;Semin Hematol,1994

3. Prophylaxis for adults with haemophilia: towards a personalised approach?;Franchini M;Blood Transfus,2012

4. Prophylaxis in adults with haemophilia

5. Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A post hoc analysis of PROTECT VIII kids assessing long‐term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A;European Journal of Haematology;2024-01-09

2. Clinical outcomes of low‐dose pharmacokinetic‐guided extended half‐life versus low‐dose standard half‐life factor VIII concentrate prophylaxis in haemophilia A patients;Haemophilia;2022-11-21

3. Hemophilia treatment in 2021: Choosing the”optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians;Blood Reviews;2022-03

4. Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study;Orphanet Journal of Rare Diseases;2021-04-28

5. The experiences and attitudes of hemophilia carriers around pregnancy: A qualitative systematic review;Journal of Thrombosis and Haemostasis;2020-05-12